Madrigal Pharmaceuticals, Inc. (MDGL) by event type
MDGL moves most on analyst upgrades — a median of -0.68% at 30 minutes across 37 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the MDGL overview →
How MDGL reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,487 of 2,717 | 37 | -0.68% | 35% | -2.10% |
| Coverage initiations 484 of 2,283 | 21 | +0.39% | 52% | -0.68% |
| Rating reiterations 3,131 of 3,522 | 91 | -0.31% | 44% | -0.17% |
| Price-target raises 315 of 1,790 | 30 | +0.15% | 57% | -0.48% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how MDGL usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · MDGL overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| INNATE PHARMA (IPHYF) | 130 | 0.00% | 0% |
| Deciphera Pharmaceuticals, Inc. (DCPH) | 129 | +0.04% | 55% |
| Medicenna Therapeutics Corp (MDNA_TSE) | 127 | 0.00% | 46% |
| OPGEN INC (OPGN) | 127 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.